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Abstract
Devices and programs using digital technology to foster or support behavior change (digital interventions) are increasingly
ubiquitous, being adopted for use in patient diagnosis and treatment, self-management of chronic diseases, and in primary
prevention. They have been heralded as potentially revolutionizing the ways in which individuals can monitor and improve their
health behaviors and health care by improving outcomes, reducing costs, and improving the patient experience. However, we are
still mainly in the age of promise rather than delivery. Developing and evaluating these digital interventions presents new challenges
and new versions of old challenges that require use of improved and perhaps entirely new methods for research and evaluation.
This article discusses these challenges and provides recommendations aimed at accelerating the rate of progress in digital behavior
intervention research and practice. Areas addressed include intervention development in a rapidly changing technological landscape,
promoting user engagement, advancing the underpinning science and theory, evaluating effectiveness and cost-effectiveness, and
addressing issues of regulatory, ethical, and information governance. This article is the result of a two-day international workshop
on how to create, evaluate, and implement effective digital interventions in relation to health behaviors. It was held in London in
September 2015 and was supported by the United Kingdom’s Medical Research Council (MRC), the National Institute for Health
Research (NIHR), the Methodology Research Programme (PI Susan Michie), and the Robert Wood Johnson Foundation of the
United States (PI Kevin Patrick). Important recommendations to manage the rapid pace of change include considering using
emerging techniques from data science, machine learning, and Bayesian approaches and learning from other disciplines including
computer science and engineering. With regard to assessing and promoting engagement, a key conclusion was that sustained
engagement is not always required and that for each intervention it is useful to establish what constitutes “effective engagement,”
that is, sufficient engagement to achieve the intended outcomes. The potential of digital interventions for testing and advancing
theories of behavior change by generating ecologically valid, real-time objective data was recognized. Evaluations should include
all phases of the development cycle, designed for generalizability, and consider new experimental designs to make the best use
of rich data streams. Future health economics analyses need to recognize and model the complex and potentially far-reaching
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costs and benefits of digital interventions. In terms of governance, developers of digital behavior interventions should comply
with existing regulatory frameworks, but with consideration for emerging standards around information governance, ethics, and
interoperability.
(J Med Internet Res 2017;19(6):e232)   doi:10.2196/jmir.7126
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Introduction
Programs and devices using digital technology (digital
interventions) have great potential to improve population health
and the efficiency and reach of health care delivery. Mobile
apps, SMS (short message service) messages, wearable and
ambient sensors, social media, and interactive websites can
improve health by supporting behaviors involved in disease
prevention, self-management of long-term conditions, and
delivery of evidence-based health care practice. Such
interventions also have potential to do harm if they provide
inappropriate advice, involve interactions that undermine desired
behaviors, inappropriately share data, or are used instead of
more effective behavior change interventions.
Many of these digital interventions seek to foster or support
behavior change on the part of health care professionals,
patients, or the general public. The challenges involved in
developing, evaluating, and implementing effective digital
behavior change interventions (DBCIs), and preventing the use
of counterproductive ones, have only just begun to be delineated,
let alone met [1]. Some of the challenges are similar to those
faced by other behavior change interventions, but many are
unique, including those of pace of development, engagement
with the intervention, measurement of effectiveness and cost
effectiveness, and compliance with regulatory, ethical, and
security requirements. These challenges are set out in more
detail in Table 1.
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Table 1. Challenges for developing and evaluating digital interventions targeting behavior change.
ChallengesTopics
Rapid technological change and iterative development cycles make it necessary to continually update and adapt
interventions.
Pace and efficiency
Existing development and evaluation cycles are slow and unsuited to dynamic systems and rapidly changing contexts.
Efficient, continuing relationships between academics and intervention developers are needed for implementation,
continued development, and evaluation.
Engagement with digital interventions is often too limited to support behavior change.Engagement
Engagement is multidimensional and cannot be evaluated simply by DBCIa usage.
Engagement with DBCIs may be unequal between different groups and at risk of reinforcing disparities or inequal-
ities.
Often, there is a lack of clarity around the mechanisms through which DBCIs have their effect.Theory
Methods of characterizing intervention components, mode of delivery, and contexts that characterize their essential
features are required but limited.
Controlling the testing environment is made problematic by the ready availability of alternative interventions.Evaluation of effectiveness
It is difficult to specify comparator interventions or control conditions that allow meaningful evaluation of the in-
tervention of interest.
Better methods for structuring and analyzing very large, dynamic, and heterogeneous data sets are needed.
Reach and engagement can be low.
The complex multi-component nature of interventions requires an iterative design and testing cycle.
There is a lack of techniques for economic and cost-effectiveness evaluation across the digital development, deploy-
ment, and delivery cycle.
Evaluation of cost-effectiveness
Funding mechanisms are not aligned with the digital model of development, implementation, iterative improvement,
and evaluation.
There are competing commercial and ethical demands on data ownership and intellectual property.Regulation, ethics, and informa-
tion governance
There are emerging and different standards around ethical or institutional review in the biomedical, psychological,
and digital development communities.
There are uncertain quality standards and regulatory processes for digital interventions (with standards either in
development or inappropriately adapted from other contexts).
aDBCI: Digital behavior change interventions.
There are also unique opportunities. For example, the type and
amount of data that can be collected creates unprecedented
potential to test and advance theories; understanding more about
human behavior will enable the development of more effective
DBCIs [2]. Rising to these challenges and making the most of
opportunities will require the expertise and collaboration of a
wide range of academic disciplines such as behavioral,
computer, and engineering sciences and user-centered design.
Given the explosion of development and use of DBCIs aimed
at improving health, there is a need for recommendations for
designing, evaluating, and implementing digital interventions
in health care. Such recommendations are needed to (1) identify
the scientific principles relevant to developing effective DBCIs,
making digital research more efficient and future interventions
safer and more effective and (2) to support key disciplines,
health care professionals, patients, and the public to work
together more effectively to advance research methods and the
understanding and techniques of behavior change through digital
technology.
To this end, an international workshop of experts in relevant
fields was convened to consider the challenges, opportunities,
and strategies for advancement and to formulate principles for
developing and evaluating DBCIs. The workshop led to a series
of publications [3-7]. This paper discusses key recommendations
arising from the workshop and subsequent discussion.
Methods
An international expert consensus-building two-day workshop,
supported by the United Kingdom’s Medical Research Council
and the National Institutes of Health and the Robert Wood
Johnson Foundation of the United States was held in September
2015 in London. The 42 participants from four countries were
selected to include those who develop, evaluate, use, and fund
DBCIs for both research and practical purposes. Participants
included health care professionals, population health researchers
(eg, systematic reviewers, behavioral scientists, and health
economists), and intervention developers. The workshop
proposal (led by SM) and steering group are shown in
Multimedia Appendix 1.
The primary deliverable from this workshop was a set of journal
articles that would summarize key issues for research in DBCIs
and a synoptic paper setting out some key recommendations.
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Six topics were identified through discussion amongst the
participants. Leaders for each topic were identified and
participants were asked to sign up to one or more topics on the
basis that they would actively contribute to writing the papers.
The topics were (1) the pace of technological development, (2)
understanding and promoting effective engagement with users,
(3) advancing models and theories, (4) evaluation strategies,
(5) economic evaluation, and (6) regulation and governance.
The writing groups met by teleconference before the workshop
to write draft papers that were circulated to the whole group in
advance of the workshop. These drafts provided the structure
and basis of the discussions at the workshop. A formal consensus
process was not used, but the structured and open discussions
did not reveal any fundamental disagreements about the nature
of the recommendations, while at the same time supporting their
refinement and specificity. Scribes were appointed from the
writing groups to take and circulate notes of relevant points for
each paper and the proceedings were audio-recorded. The
writing groups developed five articles after the workshop, now
published in the American Journal of Preventive Medicine
(AJPM) [1,3-7].
The five articles informed the recommendations presented in
this article. All authors were workshop participants (SM was
PI for the project and LY and KP were Editors of the AJPM
Special Section).
Results
The key recommendations for developing and evaluating digital
interventions are summarized in Table 2.
Achieving Rapid and Efficient Development
Behavior change interventions are moving rapidly from their
historical roots in interpersonal counseling and mass
communication to the increasingly pervasive world of ubiquitous
personal mobile and social technologies. Thus, the methods by
which we deploy, evaluate, and improve these DBCIs are
moving from relatively data-poor, infrequent, and typically
post-hoc assessments to methods that incorporate continuous
measurement of the intervention effects in real time [3]. Related
to these issues, the following recommendations emerged from
the discussion.
Consider Adopting Methods From Engineering and
Other Data-Intensive Domains in the Development Cycle
Rather than using deployment-evaluation cycles in which
successive measures are collected every few weeks or months,
a new type of rapid feedback approach is possible. Theories,
models, and methods to support this approach can be found in
systems engineering and related sectors, for example, control
theory [8], use of factorial or fractionated evaluation designs
[9], and system optimization strategies [10] (please refer to [2]
and Multimedia Appendix 2 for more details).
Use Bayesian and Related Approaches to Improve the
Predictive Modeling Capabilities of Digital Behavior
Change Interventions
In addition to enabling more agile evaluation of interventions
as they are deployed, sciences outside the traditional medical,
public health, and social or behavioral arenas can inform
modeling and prediction when multiple behaviors are addressed,
when these behaviors have consequences on other important
health-related parameters, and for all of these over time and
across populations. As with the previous recommendation, the
change in scale of the data now attainable from new technologies
is analogous to the changes that happened in the field of
meteorology when multi-scale and multilevel sensors, combined
with improved computing capabilities, enabled weather
prediction models to be rapidly built, tested, improved, and
retested [11].
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Table 2. Summary of recommendations according to topic.
Ensuring regulatory,
ethical, and informa-
tion governance
Evaluating cost-effec-
tiveness
Evaluating effective-
ness
Advancing models and
theories
Understanding and
promoting engagement
Achieving rapid and
efficient development
Ensure compliance
with appropriate ethics
or institutional review
board processes.
At every stage, includ-
ing concept develop-
ment, identify all the
relevant future costs
and benefits.
Evaluate at all phases
in the development cy-
cle.
Use the large amounts
of real-time, ecological-
ly valid data generated
by DBCIs to test and
advance models and
theories of behavior
change.
Specify and establish
empirically what consti-
tutes “effective engage-
ment” for each DBCIa,
that is, sufficient en-
gagement to achieve
the intended outcomes.
Consider adopting
methods from engineer-
ing and other data-inten-
sive domains in the de-
velopment cycle.
Identify and adhere to
regulatory processes
that may be required
for digital medical de-
vices.
Take account of project-
ed uptake as well as
reach.
Design evaluations for
generalizability.
Develop methods able
to efficiently analyze
large, complex data
sets to test dynamic
theoretical propositions
and allow personaliza-
tion of DBCIs.
Identify and develop
valid and efficient
combinations of objec-
tive and subjective
measures to build and
test multidimensional
models of engagement.
Use Bayesian and relat-
ed approaches to im-
prove the predictive
modeling capabilities
of DBCIs.
Ensure compliance
with national standards
for data handling, shar-
ing, and interoperabili-
ty, where appropriate.
Select a modeling
framework appropriate
for the complexity of
the projections.
Use methods of DBCI
evaluation that capital-
ize on their unique
characteristics.
Specify the circum-
stances in which a pro-
posed mechanism of
action of a DBCI will
produce a targeted ef-
fect and build an ontol-
ogy to organize knowl-
edge resulting from
this.
Develop DBCIs with a
person-centered and it-
erative approach, using
mixed methods to pro-
gressively refine the
DBCI to meet user re-
quirements.
Leverage advances in
data science such as
machine learning, but
ensure that human in-
put is retained as need-
ed.
Provide clear and
transparent information
on how data from the
intervention will be
used and shared.
Separately evaluate so-
cietal, personal, and
health care cost-effec-
tiveness.
Use features of DBCIs
to optimize control and
access rich data
streams.
Develop DBCIs using
a modular approach.
Choose comparators
that minimize contami-
nation.
Support interdisci-
plinary research collab-
orations and transdisci-
plinary thinking.
aDBCI: Digital behavior change interventions.
Leverage Advances in Data Science Such As Machine
Learning, But Ensure That Human Input Is Retained
As Needed
Machine learning and related approaches are increasingly being
used to solve big data challenges, including health behavior
assessment and interventions [12]. This is particularly the case
in the move beyond “on average” effects to personalized inputs
and outputs based upon each individual’s situation,
characteristics, and desired outcomes. However, we are in the
early phase of this new science, so the optimal balance between
computer-driven processes and human input is not yet clear: a
mix may be needed with the balance determined by both
qualitative and quantitative assessments of outcomes.
Understanding and Promoting Engagement
The novel ways in which interventions can be delivered using
digital technology result in new ways of engaging with them.
Face-to-face behavior change support typically requires users
to attend a set number of therapeutic or coaching sessions,
whereas users of DBCIs can access support when they feel it is
necessary. Analysis of this very different pattern of engagement
requires careful consideration of the relationship between the
“micro” level of immediate engagement with the digital
dimension of the intervention and the “macro” level of
engagement with longer-term behavior change (see next section)
[13].
Specify and Empirically Establish What Constitutes
“Effective Engagement” for Each Digital Behavior
Change Intervention, That Is, Sufficient Engagement
to Achieve the Intended Outcomes
Acknowledgement of the complex relationship between
engagement with the behavioral and technological aspects of
the intervention challenges the common assumption that
engagement can be measured simply by technology usage.
Behavior change may or may not require sustained or in-depth
engagement with the digital intervention; hence, technology
usage correlates with behavioral outcomes. However, the
association is often not strong. For some users and contexts,
just one in-depth period of engagement with the DBCI may be
sufficient to initiate new habits or teach new skills, whereas for
other types of behavior change or other users, brief but timely
context-triggered prompts may be needed long-term, whenever
the behavior is required [14]. It is therefore important to
empirically establish what the “effective” engagement required
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to achieve behavior change is, in a particular intervention context
and for any particular user, as this is likely to differ for different
types of interventions and target behaviors.
Identify and Develop Valid and Efficient Combinations
of Objective and Subjective Measures to Build and Test
Multidimensional Models of Engagement
Measuring effective engagement requires a multi-dimensional,
mixed method approach, combining objective assessment of
technology usage, behavior, and reactions to the intervention
with reports of subjective and offline experiences of users.
DBCIs promise exciting new opportunities to collect detailed
objective longitudinal data about the antecedents of behavior
change, but much work is necessary to develop and validate
reliable, non-intrusive means of assessing and analyzing user
behavior and its context. Qualitative methods are resource
intensive but provide vital complementary insights into user
views and behaviors [15]—for example, when not engaging
with the digital dimension of the intervention.
Develop Digital Behavior Change Interventions With a
Person-Centered and Iterative Approach, Using Mixed
Methods to Progressively Refine Them to Meet User
Requirements
To promote engagement with DBCIs, a “user-centered” [16] or
“person-based” [17] approach is essential to ensure that
interventions are responsive to users’ needs and preferences.
These approaches are useful in the development of any
intervention, but are particularly important for developing
DBCIs; human therapists can adjust their advice in real time
based on user reactions, whereas the content and delivery of
DBCIs must be pre-adapted during development to anticipate
a range of user reactions. This involves carrying out iterative
qualitative research and stakeholder consultation throughout
the design and development process. Tailoring interventions to
different needs and preferences can improve engagement, but
a well-designed intervention that allows choice is often
accessible and engaging for a wide range of users. Adding
human support is also known to promote engagement with many
interventions [18]. However, as tailoring and human support
both increase the cost of interventions, it is important to establish
when and how interventions need to be tailored to the individual
or supplemented by human support.
Advancing Models and Theories of Behavior Change
Digital technology makes it much easier to collect data in real
time and places less reliance on self-report when it comes to
recording behavior and taking physiological or physical
measurements of study participants or their environment. DBCIs
generate large amounts of real-time, ecologically valid data that
form digital traces that can be aggregated, connected, and
organized to gain greater understanding of how and why
behavior changes within an individual over time and how that
is influenced by internal physiological and psychological states
and the external world. To realize the potential of these data for
understanding and changing behavior, a number of
recommendations emerged from the discussion (see [4]).
Use the Large Amounts of Real-Time, Ecologically Valid
Data Generated by Digital Behavior Change
Interventions to Test and Advance Models and Theories
of Behavior Change
Data should be collected at a level of granularity that enables
the testing and advancement of models and theories of behavior
change, accounting for individual variation and changes over
time. These data should be used to build dynamic theories of
human behavior, modeling not just causal and mediating
relationships, but accounting for how effects vary across
individuals, contexts, and over time. Theories and models should
be continually tested by DBCI-generated data and the results
used to systematically refine models and theories.
Develop Methods to Efficiently Analyze Large, Complex
Data Sets to Test Dynamic Theoretical Propositions and
Allow Personalization of Digital Behavior Change
Interventions
Achieving the promise of DBCIs for advancing behavior change
theories requires methods that allow vast amounts of complex
data to be analyzed and interpreted. For theories and models to
be useful in guiding data analysis and interpreting findings, they
should be as precise, quantitative, and testable as possible [19].
This allows the building of idiographic models of behavior
change and the personalization of DBCIs, that is, the tailoring
of the DBCI content and delivery to individuals. It allows DBCIs
to adapt, as data are gathered about how the person responds in
different contexts. It also enables DBCIs to intervene at
opportune moments (sometimes referred to as ecological
momentary interventions [20] or “just-in-time” adaptive
interventions [14,21].
Specify the Circumstances in Which a Digital Behavior
Change Intervention’s Proposed Mechanism of Action
Will Produce a Targeted Effect and Build an Ontology
to Organize Knowledge Resulting From This
DBCIs represent a qualitative leap in our ability to answer the
question posed by researchers, practitioners, and policy-makers:
“What works for whom in what settings to change what
behaviors, and how?” To optimally organize knowledge about
the circumstances (when, where, for whom, and in what state
for that person) in which a proposed mechanism of action for
a DBCI will produce a targeted effect requires coherent
structures and uniform terminologies to describe constructs and
their inter-relationships [2,22]. Such knowledge-organizing
structures are called “ontologies” [22,23]. Work is beginning
to develop an ontology of behavior change interventions. The
Human Behaviour Change Project is applying artificial
intelligence to refine an ontology for analyzing the up-to-date
world literature to answer the question “What works, how well,
with what degree of exposure, for whom, in what settings, with
what behaviors, and why?” [24].
Develop Digital Behavior Change Interventions Using
a Modular Approach
To optimize the effectiveness of DBCIs, theory should be
applied to their development and the data generated should be
analyzed in terms of the underlying theoretical propositions in
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order to test and advance theory. This can be done by a modular
approach to DBCI development in which modules represent
one or more specific theoretical propositions [14]. An example
of this approach is “Drink Less,” a mobile app [25] to reduce
excessive alcohol consumption in which five theoretically
distinct modules were tested in a full factorial trial (Normative
feedback, Feedback and self-monitoring, Identity change, Action
planning, and Cognitive bias re-training) [26]. This allows the
linking of theory to intervention content, the investigation of
which techniques and mechanisms is doing the “heavy lifting”
in effective interventions and enables the cumulative process
of advancing theory and developing more effective DBCIs.
Testing and advancing theory is strengthened by supplementing
these quantitative data analytic strategies with qualitative
research methods.
Support Interdisciplinary Research Collaborations and
Transdisciplinary Thinking
Ontologies help both to organize evidence and strengthen
interdisciplinary collaboration in developing and evaluating
DBCIs informed by models and theories of behavior change.
Such collaborations, for example between behavioral scientists,
engineers, and computer scientists, will bring unique expertise
to bear upon the challenges described in this paper, but also, in
the right circumstances, generate new understandings and
knowledge that cross disciplinary boundaries, with the whole
greater than the sum of the parts [27].
Evaluating Effectiveness
Evaluating effectiveness can be challenging for any behavior
change intervention because of problems obtaining valid
outcome measures and sufficient numbers of participants who
are representative of the population of interest, fidelity in terms
of delivery of the intervention, varying levels of engagement
with the intervention, loss to follow up, and context sensitivity
of the findings. Evaluating DBCIs presents a particular blend
of challenges, some similar to other behavior change
intervention modalities and some different. Here, we highlight
some key recommendations (see [5]).
Evaluate at all Phases in the Development Cycle
Evaluation must be built into the development cycle from the
initial concept, and then carried through to prototypes and the
final implemented version. This involves concept testing, user
testing, factorial experiments, randomized controlled trials
(where feasible and appropriate), and testing against baseline
after implementation (A-B testing) [2]. For an extensive list
with definitions of options for DBCI evaluation, please see
Multimedia Appendix 2, drawn from a published guide to
developing and evaluating DBCIs in health care [2].
Design Evaluations for Generalizability
Given the high context sensitivity of DBCI effectiveness,
evaluations need to be set up in such a way that inference beyond
the strict testing conditions can be justified. Generalization may
be to different types of populations, the same type of population
at a later date, or a different implementation of the DBCI. For
example, rapidly changing fashions with regard to design and
use of interactive components means that studies need to be
designed to allow plausible generalizations beyond specific
DBCI features. Qualitative research has a contribution to make
in identifying and informing aspects of delivery and context
that increase understanding of generalizability.
Use Agile Methods of Digital Behavior Change
Intervention Evaluation That Capitalize on Unique
Characteristics
The continuous and data-intensive nature of DBCIs, combined
with the rapidly changing technologies that support them,
challenge traditional research designs such as randomized
controlled trials (RCTs) with locked-down interventions and
research approaches that involve lengthy recruitment, enrolment,
and study periods. While RCTs will continue to have value,
they should be complemented with adaptive research designs,
A/B testing, N-of-1 studies, and other research methods that
yield insights in a shorter time frame or in ways that reflect the
granular nature of the intervention effects [28]. DBCIs also
provide the opportunity to engage the user directly in the design
of the intervention, including tailoring of preferences based
upon context and changing life circumstances.
Use Features of Digital Behavior Change Interventions
to Optimize Control and Access Rich Data Streams
DBCIs can deliver complex personalized interventions with
high fidelity, and engagement with their components can be
assessed automatically. This provides an unrivalled opportunity
to undertake factorial experiments to assess the effectiveness
of components, but presents major challenges in terms of
conceptualizing and analyzing very large temporally structured
data streams. Analytical methods need to be devised to address
this challenge, but their value will be limited without a
theoretical underpinning to structuring and aggregating data.
Choose Comparators That Minimize Contamination
For many DBCIs, such as smoking cessation or weight
management apps, highly developed products are readily
available to study participants. Therefore, researchers face a
difficult choice between a comparator that has sufficient active
components to be credible and deter searching for alternatives
and one that has so much active content that the “true” effect
of the intervention cannot be measured. In practice, for many
DBCIs, we have to accept that we may never be able to assess
their full impact, only their impact relative to another active
intervention.
Evaluating Cost-Effectiveness
Rigorous economic evaluation is required to inform decision
makers about allocation of their scarce resources. A central
motivation for DBCIs is that they may be cost effective—and
certainly cheaper than their face-to-face counterparts—because
they can rapidly increase scale at minimal cost. Generating
accurate evidence of cost effectiveness will be essential in
gaining support from health system payers, but it requires
additional consideration beyond conventional analysis (see [7]).
At Every Stage, Including Concept Development, Identify
all the Relevant Future Costs
As with all interventions, economic evaluation should be
considered from the start of intervention development to ensure
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that all cost data are collected. However, existing economic
approaches (eg, ISPOR guidance [29]) will need to be adapted
to take into account the way digital health interventions are
delivered, covering the whole life cycle of the intervention. This
may include development, implementation, update, and eventual
obsolescence. While scaling interventions may be cheap, with
a low additional unit cost, development costs can be high at the
start of the process and need to be fully included in calculations.
The rapid cycle of development for many DBCIs, with multiple
versions of a product that evolves with small iterative and
incremental improvements, is different from that of the relatively
fixed products common in the pharmaceutical and medical
devices industries. The cost of these iterations must be captured
and included across the lifespan of the intervention. In addition,
as many DBCIs may be more effective when supplemented with
human interactions, evaluations may need to consider these less
cheaply scaled human costs.
Take Projected Uptake and Reach into Account
Economic evaluations will need to understand issues of uptake,
reach, and retention of the intervention, as these will be central
factors in any projection of benefit. Consideration will also need
to be given to the effects of interventions around those
immediately engaged, including effects on wider social
networks. For example, given the typically high development
costs of a DBCI, the cost-effectiveness can depend critically on
getting a large number of users. Economic evaluations need to
be able to draw on evidence as to the likely uptake of a DBCI
to assess this, which may include costs incurred in promoting
the DBCI to help drive uptake.
Select a Modeling Framework Appropriate for the
Complexity of the Projections
DBCIs are complex interventions by nature; they are responsive,
with multiple components. Economic appraisals will need to
recognize this complexity—in terms of interventions, outcomes,
and causal pathways [30]—and use appropriate methods [31]
to assess them. More complex interventions may require the
use of sophisticated modeling techniques, including agent-based
approaches, which capture dynamic interactions between the
intervention, the population it is applied to, and the wider
environment.
Separately Evaluate Societal, Personal, and Health Care
Cost-Effectiveness
Finally, cost effectiveness analysis must be diligent in measuring
effect across its forms. This might include benefit (1) to an
individual, for example, in improved quality of life, (2) to
society, for example, in improved productivity of the workforce,
and (3) to the health care system, for example, in reduced
referrals to conventional face-to-face settings or hospital
admissions. Ideally, disaggregation of these separate components
should be attempted, if possible.
Ensuring Regulatory, Ethical, and Information
Governance
Beyond the practical and measurable aspects of development
and evaluation, DBCIs present new questions in terms of ethics
and regulation as they challenge existing frameworks and rules
often designed in a pre-digital era.
Ensure Compliance With Rules on Ethics or Institutional
Review Board Processes
The diversity of disciplines involved in the development of new
DBCIs is challenging as the expectations and approaches of
different cultures involved may not be immediately aligned.
The notion of a minimum viable product and “fail fast, fail
often” might be encouraged in an engineering world view, but
it stands in sharp contrast to the “first do no harm” spirit of the
health care profession and the risk-averse nature of clinical
governance and patient safety. Developers may need to adjust
to the more stringent regulatory frameworks of the biomedical
sector and local ethics or institutional review processes. At the
same time, regulators will need to make improvements in terms
of speed and responsiveness in order to be able to meet the needs
of fast evolving technologies. This was emphasized in the United
States in a 2016 report from the National Academies of Science,
Engineering, and Medicine [32], which advocated reflecting
the contemporary realities of new research contexts, including
accessibility and use of personal data.
Identify and Adhere to Regulatory Processes That May
Be Required for Digital Medical Devices
DBCIs will need to navigate the complex landscape of regulation
and governance. Many of these interventions fall at the blurred
edges of existing regulatory frameworks, which evolved in a
pre-digital and less software-intensive era. Depending on their
nature, many DBCIs will be classified as medical devices. A
lack of consistency of approach between countries means that
those developing interventions will need to carefully monitor
and engage with the emerging frameworks of the jurisdictions
they work within. Regulatory organizations include the United
Kingdom’s Medicines & Healthcare Products Regulatory
Agency, which has issued specific guidance on apps [33] and
the US Federal Trade Commission, which has released similar
advice [34]. In addition, although several frameworks for
assessment exist, there is diversity in views about what the
necessary domains of quality are for DBCIs. Developers will
need to understand this variation and create the appropriate
evidence to match these specifications. Developing assessment
frameworks in the United Kingdom include the National Health
Service (NHS) app assessment model [35] and the European
Union mHealth assessment guidelines [36].
Ensure Compliance With National Standards for Data
Handling, Sharing, and Interoperability, Where
Appropriate
There are unique challenges of information governance, as
DBCIs may produce large amounts of personal, identifiable,
and potentially valuable data. As data is often collected directly
from mobile devices, this may include geographical information
or information related to contacts and social networks. Those
developing interventions will have to comply with local
legislation that varies in scope and detail. Relevant legislation
includes the Health Insurance Portability and Accountability
Act (HIPAA) [37] in the United States, the Data Protection Act
[38] (together with the Caldecott principles) in the United
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Kingdom, and the General Data Privacy Regulation in the EU
[39]. In addition, DBCIs may have more benefit if they are able
to formally interact with health care delivery systems and, in
particular, with electronic health records, requiring compatibility
with local (and often highly variable) standards.
Provide Clear and Transparent Information on How
Data From the Intervention Will Be Used and Shared
Beyond the essential regulatory frameworks, there are wider
societal questions that have not yet been definitively answered
regarding acceptability of data collection and sharing with
competing commercial and ethical demands on data ownership.
Some interventions are provided on a fee-for-use basis. Others
have more complicated business models where a product is
provided for free, but data is made available to the provider.
There may be a trade-off that the public is willing to make
between sharing their own data, effectiveness of interventions,
and cost. As the threshold of acceptability is still being
understood—and as this threshold may vary between populations
and individuals—developers will need to tread cautiously and
transparently. In addition, ownership of the data produced by
DBCIs is not always clear and may vary by jurisdiction. These
data have the potential to be a valuable resource for health care
research and service planning [40], but the public may not be
aware of these potential uses and may have reservations about
how the data are used [41]. Developers should provide clarity
about how and with whom they share their data. They may also
wish to make sure that the business model for provision of their
intervention is openly reported.
Discussion
Future Research
The approaches used to address the compelling health problems
of our times should be based in state-of-the-art science in
medicine, public health, and the social and behavioral sciences.
They must also reflect advances in other disciplines such as
engineering, data science, systems science, human-computer
interaction, and communications technologies, in particular if
these promise to improve the means by which we both
understand the determinants of health and improve health
behaviors. Innovations in digital health are now emerging on
several fronts that demonstrate the utility of methods drawn
from these fields. This should not surprise anyone who is
engaged as a digital citizen in the increasingly smart and
connected world in which we now live. The mobile in our
pockets, purses, or backpacks is becoming both an increasingly
important window on the potential of digital health and an
enabler thereof. Thus, there is a need to consider several
implications of these developments and optimally shape them
as they go forward.
The ways in which users engage with digital interventions are
changing as fast as the technologies for delivering them, and it
is important that our methods of conceptualizing and assessing
engagement keep pace. Earlier, PC-based digital interventions
often replicated a series of therapeutic or coaching “sessions,”
and engagement was defined simply as completing sufficient
sessions to receive the full therapeutic program. However,
mobile users of just-in-time adaptive interventions may just
engage briefly at the crucial time-point with precisely the
required behavior change support. The “effective” engagement
required for behavior change support is therefore likely to differ,
depending on the users and their contexts, and can only be
determined by analyzing complex patterns of relationships
between usage, user experiences, and outcomes. A challenge
for future research into DBCIs is to find the most valid and
efficient combinations of methods of measuring engagement
with the intervention, both on the Internet and offline.
Technology can provide detailed, unobtrusive assessment of
behavior and its context, while complementary qualitative
methods are crucial to fully understand and interpret user
experiences. These qualitative approaches are central to
participatory user-centered design, which is the key to
developing and evaluating DBCIs in order to ensure that they
are engaging and effective [16,17].
With respect to theory, DBCIs provide an unprecedented
opportunity to test and advance our understanding of how
behavior changes. However, this requires the application of
more “agile” science [42]. This includes designing DBCIs on
a modular basis with a clear understanding of which behavior
change techniques [43] constitute that module and how they
link to the theoretically postulated mechanisms of action.
Collaborations between behavioral scientists and computer
scientists are enabling theories of change to be specified in
precise detail as sets of constructs and specified relationships
between them. Computational models can define and test not
just interactions between modules, mechanisms of action, and
behaviors, but also how these vary across individuals and
populations, settings, and time. This is spawning a fruitful area
of “ontology” development, ontologies being well specified
structures for organizing knowledge [22]. By combining this
with computational algorithms and machine learning, the
promise is that we can advance theoretical understanding of
behavior change so that we can answer with confidence the
questions put by health practitioners and policy makers: “What
works, how well, for whom, in what settings, for what behaviors,
and why?” [24].
With respect to evaluation, one key effectiveness question for
policy makers and practitioners is whether purchasing or
commissioning a given intervention will improve outcomes for
their population compared with current practice or another
innovation that they may be considering. Another is whether
digital interventions can reduce the cost of health care provision
without a significant loss of effectiveness. Ideally, this would
involve pragmatic randomized trials (individual or cluster)
comparing the different forms of care. However, the analysis
in this paper indicates that this is often impracticable. Moreover,
there are so many unknowns in the development of these
interventions that a much more iterative cycle of development
and testing is needed before getting to the point of a pivotal
evaluation. Even when an intervention has been found to be
effective in a pivotal evaluation, there are no guarantees that it
will continue to be effective in a rapidly changing context. This
means that the evaluation strategy for DBCIs needs to be fully
integrated into every phase of development and implementation
and needs to take advantage of the wide range of methodologies
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that are available, both experimental and observational, while
also taking into account the exposure as well as effect in those
exposed. The evaluation needs to take advantage of statistical
techniques, particularly Bayesian analyses that promote ongoing
accumulation of evidence.
With respect to the economic evaluation, policy makers and
service providers will be hungry for the potential to deliver
interventions at scale with only small increases in marginal cost,
often in comparison with face-to-face interventions. This creates
a requirement for evaluators to adapt existing economic
approaches and develop new ones to accurately capture cost
across the full digital development cycle, measure the reach of
the intervention, and consider the complexity of the intervention
to allow meaningful comparison. In evaluating both
effectiveness and cost effectiveness, policy makers and
organizations that consider purchasing these services will need
to compare them with conventional delivery models and
evaluation approaches. Thus, developers and evaluators will
need to ensure that they produce evidence that allows this
comparison to be made.
With respect to ethical, regulatory, and policy issues, standards
for DBCIs are still emerging, and people developing and testing
them will have to pick a cautious path through rules not often
designed with this new category of interventions in mind. They
will need to ensure that new, agile approaches to testing DBCIs
demonstrate that they meet the exacting expectations of the
clinical and biomedical community. Possibilities to develop
common standards for intra-operability between interventions,
with electronic health records and health care delivery systems,
and in common behavioral data repositories should be explored.
The advice provided here is specific to DBCIs, but it should
also build on the good practice of reporting general mHealth
interventions published elsewhere to ensure adequate description
of the technical components of the intervention [44,45].
Conclusions
DBCIs present unique methodological challenges. New
techniques and approaches are becoming available that offer
opportunities to accelerate both the development and evaluation
of these interventions, taking advantage of the speed and volume
of data they generate, their potential adaptability, reach, and
cost. These new methods have implications for changes within
other fields of health care.
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